SELLAS Life Sciences Announces Pricing of $20.0 Million Underwritten Public Offering
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (Nasdaq: SLS)…
Month: February 2023
Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis
Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France,…
Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
CAMBRIDGE, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
Frontier’s Record Quarter Accelerates Transformation to Growing Digital Infrastructure Company
Reports Fourth-Quarter and Full-Year 2022 Financial Results NORWALK, Conn.–(BUSINESS WIRE)–Frontier Communications Parent, Inc. (NASDAQ: FYBR)…
Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office
New Patent Adds to the Istaroxime Patent Estate and Provides Intellectual Property Protection Until Late…
Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT™ and Virtue® SAB at CRT 2023
NEW HOPE, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO,…
Libtayo® (cemiplimab) in Combination with Chemotherapy Receives Positive CHMP Opinion for the Treatment of Advanced PD-L1 Positive Non-small Cell Lung Cancer (NSCLC)
Recommendation based on a Phase 3 trial demonstrating superior survival outcomes for Libtayo plus chemotherapy…
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2022 Financial Results and Business Update
Conference call to be held Tuesday, February 28, 2023 at 8:30 AM ET NEW YORK,…
Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330
WTX-330 is designed as systemically delivered, conditionally activated IL-12 therapy Phase 1 Study of WTX-330…
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer
If approved, niraparib in combination with abiraterone acetate (AA), will be the first dual action tablet…
Orchard Therapeutics Announces Presentation of Updated Integrated Analysis of OTL-200 in MLD and Reports Progress with Newborn Screening Efforts at the 19th Annual WORLDSymposium™
Administration of one-time gene therapy resulted in statistically significant improvement in severe motor impairment-free survival…
Federated Wireless Partners with AURA Network Systems to Advance Autonomous Aviation with Spectrum Management in the 450 MHz Band
Aviation network innovator selects Federated Wireless to jointly develop spectrum management system for crewed and…
Aicon Yachts, a 2022 Award Winning Yacht Builder to Offer and Distribute Energy Glass Solar(TM), a Patented Electric Collecting Glass for Yachts in the 66 Ft to 100 Ft Category
Scottsdale, Arizona–(Newsfile Corp. – February 24, 2023) – Saxon Capital Group, Inc. (OTC Pink: SCGX),…
Legend Power(R) Systems Reports Q1 F2023 Financial Results
Vancouver, British Columbia–(Newsfile Corp. – February 24, 2023) – Legend Power® Systems Inc. (TSXV: LPS)…
Champion REIT Announces 2022 Annual Results
HONG KONG, Feb 24, 2023 – (ACN Newswire) – Champion Real Estate Investment Trust (stock…
Hecla to Participate at Upcoming Conferences
COEUR D’ALENE, Idaho–(BUSINESS WIRE)–Hecla Mining Company (NYSE:HL) announced today that representatives of the Company will…
Merck and Ridgeback Provide Update on EU Marketing Authorization Application for LAGEVRIO™ (Molnupiravir)
RAHWAY, N.J. & MIAMI–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States…
BITNILE.COM Announces Creation of “NILE” Coin Available Exclusively for In-World Use on BITNILE.COM
LAS VEGAS–(BUSINESS WIRE)–$AP #AULT—Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company formerly known…
HF Sinclair Corporation Reports 2022 Fourth Quarter and Full Year Results and Announces Increase in Regular Cash Dividend
Fourth Quarter Reported net income attributable to HF Sinclair stockholders of $587.0 million, or $2.92…